Hanmi Pharm. Co., Ltd.
KRX:128940.KS
256000 (KRW) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||||
Net Income
| 146,231.159 | 101,558.192 | 81,478.224 | 17,289.715 | 63,867.248 | 34,156.166 | 68,973.581 | 30,299.648 | 162,060.447 | 43,295.071 | 50,534.448 | 28,754.748 | 5,426.021 | -8,936.904 |
Depreciation & Amortization
| 98,453.98 | 96,842.007 | 89,086.339 | 61,339.065 | 55,412.168 | 47,193.594 | 36,460.268 | 38,862.741 | 50,131.101 | 25,392.316 | 27,088.673 | 33,513.358 | 35,701.521 | 19,173.346 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -57,396.645 | -73,686.284 | -53,516.151 | 42,074.209 | -136,954.562 | -97,926.042 | -166,281.166 | 331,523.346 | -116,706.576 | -94,068.853 | -1,524.707 | -11,149.502 | 4,621.771 | 4,950.892 |
Accounts Receivables
| -2,602.85 | 38,190.084 | -74,313.912 | 33,651.938 | -10,519.94 | 55,682.165 | 1,545.013 | 514,133.618 | -494,858.327 | 0 | 0 | 0 | 0 | 0 |
Inventory
| -16,902.572 | -14,365.31 | 18,915.72 | 4,884.619 | -74,098.117 | -27,129.927 | -42,728.102 | -34,681.663 | -24,783.108 | -26,984.446 | 11,097.738 | -9,845.267 | 10,329.859 | 282.777 |
Accounts Payables
| 5,574.242 | -2,736.13 | 9,794.149 | -5,307.995 | -7,144.409 | 3,337.211 | -3,303.849 | -7,527.953 | 3,237.482 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -43,465.465 | -94,774.928 | -7,912.109 | 8,845.647 | -45,192.096 | -129,815.491 | -123,553.064 | 366,205.009 | -91,923.468 | -67,084.407 | -12,622.445 | -1,304.236 | -5,708.088 | 4,668.115 |
Other Non Cash Items
| 29,249.122 | 37,555.028 | 84,874.796 | 30,831.961 | 30,121.767 | 42,558.538 | -2,057.884 | 12,279.441 | 6,227.319 | -7,438.242 | 9,893.107 | 12,149.598 | 15,554.586 | 3,756.778 |
Operating Cash Flow
| 216,537.615 | 162,268.943 | 201,923.207 | 151,534.95 | 12,446.62 | 25,982.256 | -62,905.201 | 412,965.176 | 101,712.291 | -32,819.709 | 85,991.521 | 63,268.202 | 61,303.899 | 18,944.112 |
Investing Activities: | ||||||||||||||
Investments In Property Plant And Equipment
| -47,746.546 | -49,593.078 | -34,424.929 | -57,839.483 | -178,373.838 | -211,231.513 | -262,330.867 | -224,091.955 | -137,030.817 | -80,341.455 | -34,906.909 | -20,343.354 | -30,055.125 | -26,526.16 |
Acquisitions Net
| 0 | -25,771.99 | -14,112.281 | -15,853.814 | -9,396.357 | -606.504 | -9,952.395 | -22,673.026 | -12,398.76 | -10,089.647 | -4,107.789 | -5,416.575 | -9,509.317 | -5,251.506 |
Purchases Of Investments
| -94,770.16 | -92,923.179 | -7,738.635 | -2,537.348 | -31,928.034 | 28,963.505 | -121,414.137 | -758,740.575 | -16,435.4 | -76,550 | -21,080.52 | -32,072.777 | -1,911.155 | -193.47 |
Sales Maturities Of Investments
| 90,377.511 | 86.584 | 785.902 | 16,531.606 | 36,595.527 | 64,900.595 | 225,381.388 | 626,521.895 | 35,224.415 | 86,615.304 | 13,424.374 | 10,032.446 | 116.9 | 3,329.116 |
Other Investing Activites
| -131,333.004 | -13,206.42 | 12,101.107 | 14,532.836 | 10,159.164 | -27,853.979 | 15,428.419 | 23,834.919 | 16,265.792 | 11,162.468 | 8,337.938 | 6,494.769 | 2,177.734 | -1,570.008 |
Investing Cash Flow
| -183,472.198 | -181,408.084 | -43,388.835 | -45,166.203 | -172,943.538 | -145,827.896 | -152,887.592 | -355,148.743 | -114,374.771 | -69,203.33 | -38,332.906 | -41,305.491 | -39,180.963 | -30,212.028 |
Financing Activities: | ||||||||||||||
Debt Repayment
| -103,371.36 | -140,240.484 | -99,671.36 | -51,286.16 | 210,436.76 | 155,106.422 | 144,315.119 | -35,397.469 | 95,026.027 | -8,701.994 | -31,900.647 | 12,443.436 | -21,213.924 | -15,045.005 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 94,341.153 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| -3,070.611 | -3,834.087 | -4,873.541 | -3,083.209 | -3,866.824 | -5,588.023 | -6,450.109 | -7,127.145 | -408.565 | -516.528 | -347.706 | -174.06 | -294.837 | -411.438 |
Dividends Paid
| -17,995.573 | -5,992.225 | -5,881.33 | -8,140.39 | -5,662.345 | -8,956.207 | 0 | -20,420.26 | 0 | 0 | 0 | 0 | -155.4 | 0 |
Other Financing Activities
| -2,349.123 | 113,200 | -2,904.405 | -2,680.295 | -2,309.443 | -118.683 | -118.683 | 0 | -72.588 | -0 | 0 | -65.888 | -244 | 23,139.675 |
Financing Cash Flow
| -126,786.667 | -36,866.795 | -113,330.636 | -65,190.053 | 198,598.148 | 140,443.509 | 137,746.327 | -62,944.874 | 94,544.874 | 85,122.631 | -32,248.353 | 12,203.488 | -21,908.161 | 7,683.232 |
Other Information: | ||||||||||||||
Effect Of Forex Changes On Cash
| 1,372.919 | -5,890.035 | 17,863.521 | -1,134.388 | 673.639 | -525.703 | -5,059.837 | -2,828.372 | 3,975.792 | 73.379 | -1,272.462 | -633.063 | 2,452.479 | -197.293 |
Net Change In Cash
| -92,348.331 | -61,895.971 | 63,067.257 | 40,044.305 | 38,774.869 | 20,072.167 | -83,106.303 | -7,956.812 | 85,858.187 | -16,827.03 | 14,137.801 | 33,533.135 | 2,667.254 | -3,781.977 |
Cash At End Of Period
| 54,980.324 | 147,328.655 | 209,224.626 | 146,157.369 | 106,113.064 | 67,338.195 | 47,266.027 | 130,372.331 | 138,329.143 | 52,470.957 | 69,297.986 | 55,160.185 | 21,627.05 | 12,140.958 |